# Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes

> **NCT00094341** · PHASE4 · COMPLETED · sponsor: **Amgen** · enrollment: 215 (—)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT00094341
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 215 (—)
- **Last updated:** 2008-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00094341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00094341, "Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00094341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*